In chronic kidney disease (CKD) mouse models, the downregulation of miR-486 was found to be connected to an increase in MAFbx/MuRF1 and atrogin1 expression, and a consequent increase in muscle protein degradation [150]. The gene discussed is FBXO32; the disease is chronic kidney disease.